Agent experience (AX) is the new competitive advantage in the era of AI. Learn how B2Ai commerce is transforming marketing ...
IRADIMED CORPORATION (the 'Company” or 'Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and ...
When Continuum opened in the West Village in 2024, there were a lot of headlines about the $100,000-a-year wellness club — ...
That legal framing sets the stage for “Getting past ‘no’ when the patient needs to go,” in which Samantha Johnson, Esq.; and ...
As China's new drug R&D enters the "deep waters" of homogeneous competition, the path for followers has become increasingly crowded. Target congestion, rising costs, and intensifying global races have ...
Roche’s phase III FENtrepid study of fenebrutinib meets its primary endpoint of non-inferiority compared to Ocrevus in reducing disability progression in patients with PPMS ...
Investigators have reported that three doses of the anti-programmed cell death protein 1 immunotherapy pembrolizumab – given ...
Machine design engineers working in the medical device field might draw inspiration from AuraWell’s iterative, ...
Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...
Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.
Five poster presentations highlight clinical advancement of neffy, real-world usability and advantages of needle-free epinephrine delivery ...
Q4 2025 Earnings Call February 10, 2026 6:45 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results